To view this email as a web page, click here

Today's Rundown

Featured Story

J&J, BARDA pick 7 startups to back in fight against COVID-19—and beyond

As the world scrambles to develop diagnostics, treatments and vaccines for COVID-19, one big question looms: How will we face the next pandemic? Johnson & Johnson and the U.S. Biomedical Advanced Research and Development Authority are teaming up once again to answer that.

read more

Top Stories

Biotech behind AstraZeneca's COVID-19 vaccine advances next-gen prospect

Vaccitech has received U.K. government funding for a COVID-19 vaccine that it thinks can improve on first-generation prospects such as the AstraZeneca jab it helped develop. 

read more

Bayer backs Triumvira to take CAR alternative into clinic

Bayer has co-led a $55 million investment in cell therapy startup Triumvira Immunologics. Triumvira will use the series A funding to run clinical trials of cell therapies that are directed by an alternative to CARs.

read more

Sponsored: Improve outcomes for TIL therapies by tackling process challenges

The efficacy of TIL therapies depends on how the original tumor samples are collected, harvested, and processed.

read more

Dermavant's psoriasis cream hits the mark in phase 3, teeing up FDA filing

Two years ago, Dermavant forked over £150 million upfront to get its hands on GlaxoSmithKline’s phase 3-ready psoriasis cream. Now, with positive phase 3 data in hand, the company is ushering the drug toward an FDA filing in 2021. The cream, tapinarof, outshone an inactive cream in two identical phase 3 studies that together enrolled more than 1,000 patients

read more

Amid gene therapy hold, Solid Bio's ex-CMO joins Apic

A month after the FDA kept its clinical hold on Solid Biosciences’ experimental gene therapy treatment, the biotech’s former chief medical officer has landed at Apic.

read more

CRISPR treats obesity in mice by turning harmful fat into energy-burning cells

A research team led by scientists at Harvard University used the CRISPR-Cas9 gene-editing tool to engineer harmful white fat so that it would take on the properties of calorie-burning brown fat. They believe the advancement will open up the possibility of cell therapies to combat obesity and other metabolic diseases.

read more

Abbott to ship millions of $5, card-sized coronavirus tests offering 'digital health passes'

The FDA has given its green light to a new coronavirus test from Abbott, which will be sold for $5 and fits entirely on a device about the size of a credit card.

read more

Enrollment Showcase

Bioscience Certificate Pathways Advancing Knowledge, Skills, & Careers

Taught by experienced professionals, Biotility’s online short courses provide the knowledge and practical skills valued by the bioscience industry. Enhance your career through coursework in one of our certificate pathways, including Document Management, Operations Management, and Quality Management. Learn more.

Resources

Whitepaper: Top 7 Data Points from Medical Claim Forms to Drive Market Development

Traditionally, pharma companies use a combination of prescription data & internal sales reports to look for potential buyers. Such practice provides only a LIMITED VIEW without competitor information.

Whitepaper: New data models to gain insight on medication adherence

Download the whitepaper by Optum to see how novel data platforms can uncover hidden insights on medication adherence helping life sciences companies maximize product utilization.

Webcast: DRUG ABUSE LIABILITY ASSESSMENT: Are you taking an integrated approach?

Two informative webcasts will present practical and methodological approaches to preclinical drug abuse liability assessment

Report: Decentralized Trials - Where Does the Industry Stand?

Patient-facing digital technologies are playing an important role in clinical trials for new drugs and medical devices, to the point where conducting virtual trials is becoming mainstream. But terms like remote trials, direct-to-patient trials, hybrid trials, decentralized trials, and more all add to the confusion of what makes a trial "virtual."

Whitepaper: Navigating the Changing Clinical Trial Landscape

The research conducted here is to help understand and solve the top challenges in clinical operations, to remove barriers that are slowing down our ability to bring new drugs to market as quickly as possible to patients waiting in need.

Whitepaper: Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs

How to select the right dosage form for your Phase I clinical supply.

Whitepaper: Quality by Design: A Holistic Approach to Drug Development

Quality by Design (QbD) reduces risk within drug development, while bringing therapies to market quicker.

Executive Summary: Keys to a Successful Rapid Commercial Launch

Pharmaceutical and biotech companies are spending years developing drugs or promising new biologics, all with the hopes of saving or enhancing patients’ lives. It’s a “race to the finish” in some cases, and the quicker a company can get its product to patients, the better.

Whitepaper: More Powerful Analytics Capabilities

Case Study: Oncology-focused pharmaceutical company strengthens product launch by identifying hundreds of high-value physicians with Acorn AI.

eBook: Navigating the Insulin Affordability Act

Download the whitepaper for a solution designed to connect manufacturers, pharmacists, and patients. In this special guide, you will learn not just about the law but about the portal platform designed to change the entire process for all.

Whitepaper: Reducing the Complexity and Costs of Channel Planning and Logistics

Identifying opportunities to simplify channel strategies and business processes for biopharma companies, their customers and patients.

Whitepaper: The Art of Recognizing Clinical Supply Risk Factors

In a BioPharma Dive industry survey, planning and forecasting were identified as top concerns for trial sponsors. In response to this need, the CSM team at Catalent has developed a methodology for identifying, evaluating, and proactively managing the inherent risks involved in clinical trial supply chain management.

Whitepaper: Learn How Collaboration (Not Competition) Will Bring Better Pediatric Medicines to Market

Drug developers and stakeholders must find ways to collaborate, rather than compete, as the RACE Act prompts the need for more pediatric research.

Case Study: Establishing Parameters for Success

Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study.

Fact Sheet: Forecasting to Optimize Clinical Trial Supply Management

Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study.

eBook: Expecting the Unexpected: Strategies for Efficient Clinical Supply Management and Forecasting

Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study.

Events